| Secondary |
| Product Used For Unknown Indication |
31.5% |
| Drug Use For Unknown Indication |
20.1% |
| Pain |
17.2% |
| Back Pain |
4.4% |
| Hypertension |
3.3% |
| Oral Neoplasm |
3.2% |
| Cancer Pain |
2.9% |
| Depression |
2.7% |
| Insomnia |
2.0% |
| Hypersensitivity |
1.8% |
| Analgesic Therapy |
1.5% |
| Infection |
1.2% |
| Anxiety |
1.1% |
| Chemotherapy |
1.1% |
| Gastric Cancer |
1.1% |
| Abdominal Pain |
1.0% |
| Decreased Appetite |
1.0% |
| Herpes Zoster |
1.0% |
| Oral Pain |
1.0% |
| Pain In Extremity |
1.0% |
|
| Somnolence |
14.4% |
| Vomiting |
13.5% |
| Thrombocytopenia |
9.9% |
| Renal Failure Acute |
6.3% |
| Disorientation |
5.4% |
| Fall |
5.4% |
| Hepatocellular Injury |
5.4% |
| Hyponatraemia |
3.6% |
| Renal Failure |
3.6% |
| Respiratory Distress |
3.6% |
| Rhabdomyolysis |
3.6% |
| Toxic Skin Eruption |
3.6% |
| Agranulocytosis |
2.7% |
| Coma |
2.7% |
| Confusional State |
2.7% |
| Death |
2.7% |
| Drug Dependence |
2.7% |
| Drug Ineffective |
2.7% |
| Intestinal Obstruction |
2.7% |
| Ovarian Cancer |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.9% |
| Product Used For Unknown Indication |
16.9% |
| Pain |
13.4% |
| Unevaluable Event |
3.8% |
| Gastric Cancer |
3.7% |
| Hypertension |
3.7% |
| Non-small Cell Lung Cancer |
3.3% |
| Anxiety |
2.7% |
| Chest Pain |
2.4% |
| Multiple Myeloma |
2.4% |
| Bone Pain |
2.3% |
| Constipation |
2.1% |
| Depression |
2.0% |
| Diffuse Large B-cell Lymphoma |
1.8% |
| Insomnia |
1.7% |
| Prophylaxis |
1.7% |
| Nausea |
1.6% |
| Breast Cancer Metastatic |
1.6% |
| Abdominal Pain |
1.5% |
| Back Pain |
1.5% |
|
| Thrombocytopenia |
13.0% |
| Vomiting |
11.9% |
| General Physical Health Deterioration |
7.9% |
| Neutropenia |
6.8% |
| Sepsis |
6.8% |
| Stevens-johnson Syndrome |
5.6% |
| Drug Eruption |
5.1% |
| Pulmonary Embolism |
4.5% |
| Renal Failure Acute |
4.5% |
| Weight Decreased |
4.5% |
| Somnolence |
4.0% |
| International Normalised Ratio Increased |
3.4% |
| Renal Failure |
3.4% |
| Agranulocytosis |
2.8% |
| Hyponatraemia |
2.8% |
| Off Label Use |
2.8% |
| Petechiae |
2.8% |
| Toxic Skin Eruption |
2.8% |
| Acute Generalised Exanthematous Pustulosis |
2.3% |
| Cholestasis |
2.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
54.0% |
| Cancer Pain |
6.9% |
| Headache |
6.9% |
| Migraine |
6.9% |
| Pain In Extremity |
5.7% |
| Constipation |
4.6% |
| Amputation Stump Pain |
3.4% |
| Erysipelas |
3.4% |
| Neoplasm Malignant |
3.4% |
| Product Used For Unknown Indication |
2.3% |
| Lymphangitis |
1.1% |
| Neuropathy |
1.1% |
|
| Pneumonia Aspiration |
21.4% |
| Orthostatic Hypotension |
14.3% |
| Pain |
14.3% |
| Syncope |
14.3% |
| Hallucination |
7.1% |
| Oedema Peripheral |
7.1% |
| Partial Seizures |
7.1% |
| Somnolence |
7.1% |
| Volume Blood Decreased |
7.1% |
|
